Here is the latest shareholding Pattern of SHREE GANESH BIOTECH. For more details, see the SHREE GANESH BIOTECH financial fact sheet and SHREE GANESH BIOTECH share price.
No. of Mths Qtr. Ending |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
3
Jun-24 |
3
Sep-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 2.42 | 2.42 | 2.42 | 2.17 | 2.17 | 1.42 | 1.42 | 1.42 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 2.42 | 2.42 | 2.42 | 2.17 | 2.17 | 1.42 | 1.42 | 1.42 | |
Bodies Corporate | % | 3.48 | 3.40 | 1.24 | 5.50 | 1.33 | 1.02 | 0.20 | 0.20 | |
Individuals | % | 64.73 | 65.64 | 68.93 | 81.44 | 93.18 | 94.65 | 95.39 | 95.30 | |
NRIs/OCBs | % | 1.26 | 1.47 | 1.58 | 1.62 | 2.33 | 1.76 | 1.81 | 1.78 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 28.11 | 27.07 | 25.83 | 9.27 | 0.99 | 1.15 | 1.18 | 1.30 | |
Total Non-Institution | % | 97.58 | 97.58 | 97.58 | 97.83 | 97.83 | 98.58 | 98.58 | 98.58 | |
Total Public | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Agriculture Company Shareholding Pattern: ADANI ENTERPRISES ZOMATO ADANI PORTS & SEZ ADANI TOTAL GAS APOLLO HOSPITALS
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.